Maggot therapy takes us back to the future of wound care: New and improved maggot therapy for the 21st century

Journal of Diabetes Science and Technology

Volumn 3, Issue 2, 2009, Pages 336-344

  Sherman, Ronald A ^a,b,c  

^a DERMATOLOGY RESEARCH AND EDUCATION FOUNDATION   (United States)

^b Orange County Health Care Agency   (United States)

^c Monarch Labs LLC   (United States)

Author keywords

Diabetes; Larva; Maggot; Therapy; Ulcer; Wound

Indexed keywords

ANIMAL; BANDAGE; DEBRIDEMENT; DIABETES MELLITUS; HUMAN; INFECTION; INJURY; LARVA; METHODOLOGY; REVIEW;

ANIMALS; BANDAGES; DEBRIDEMENT; DIABETES COMPLICATIONS; HUMANS; INFECTION; LARVA; WOUNDS AND INJURIES;

EID: 77952007912     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300215     Document Type: Review

References (89)

1. Frykberg RG, Armstrong DG, Giurini J, Edwards A, Kravette M, Kravitz S, Ross C, Stavosky J, Stuck R, Vanore J, American College of Foot and Ankle Surgeons. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg. 2000;39(5 Suppl):S1-60.
2. [Updated in J Foot Ankle Surg. 2006;45(5 Suppl):S1-66.]
3. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ. 2002;324(7330):160-3.
4. McGuckin M, Kerstein MD. Venous leg ulcers and the family physician. Adv Wound Care. 1998;11(7):344-6.
5. Petrie NC, Yao F, Eriksson E. Gene therapy in wound healing. Surg Clin North Am. 2003;83(3):597-616.
6. Frykberg RG, Habershaw GM, Chrzan JS. Epidemiology of the diabetic foot: ulcerations and amputations. In: Veves A, ed. Contemporary endocrinology: clinical management of diabetic neuropathy. Totowa: Humana Press; 1998, p. 273.
7. Centers for Disease Control and Prevention. National diabetes fact sheet, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. http://www.cdc.gov/diabetes/pubs/pdf/ndfs- 2007.pdf. Accessed February 22, 2009.
8. Pechter EA, Sherman RA. Maggot therapy: the surgical metamorphosis. Plast Reconstr Surg. 1983;72(4):567-70.
9. Baer WS. Sacro-iliac joint - arthritis deformans - viable antiseptic in chronic osteomyelitis. Proc Int Assembly Interstate Postgrad Med Assoc North Am. 1929;371:365-72.
10. Baer WS. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg. 1931;13:438-75.
11. Robinson W. Progress of maggot therapy in the United States and Canada in the treatment of suppurative diseases. Am J Surg. 1935;29:67-71.
12. Horn KL, Cobb AH Jr, Gates GA. Maggot therapy for subacute mastoiditis. Arch Otolaryngol. 1976;102(6):377-9.
13. Teich S, Myers RA. Maggot therapy for severe skin infections. South Med J. 1986;79(9):1153-5.
14. Sherman RA. A new dressing design for use with maggot therapy. Plast Reconstr Surg. 1997;100(2):451-6.
15. Sherman RA, Tran JM, Sullivan R. Maggot therapy for treating venous stasis ulcers. Arch Dermatol. 1996;132(3):254-6.
16. Fleischmann W, Thoener B. Biobag: a live wound-dressing containing maggots. Presented at: Fifth International Conference on Biotherapy. Wurzburg, Germany. 2000.
17. Grassberger M, Fleischmann W. The biobag: a new device for the application of medicinal maggots. Dermatology. 2002;204(4):306.
18. Sherman RA, Wyle FA. Low-cost, low-maintenance rearing of maggots in hospitals, clinics, and schools. Am J Trop Med Hyg. 1996;54(1):38-41.
19. Livingston SK, Prince LH. The treatment of chronic osteomyelitis with special reference to the use of the maggot active principle. J Am Med Assoc. 1932;98:1143-9.
20. Wilson EH, Doan CA, Miller DF. The Baer maggot treatment of osteomyelitis. Preliminary report of twenty-six cases. JAMA. 1932;98:1149-52.
21. Robinson W, Norwood VH. The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Surg. 1933;15:409-12.
22. Livingston SK. The therapeutic active principle of maggots with a description of its clinical application in 567 cases. J Bone Joint Surg. 1936;18:751-6.
23. Sherman RA, Wyle F, Vulpe M, Wishnow R, Iturrino J, Watson M, Martin G. Maggot therapy for treating pressure sores in spinal cord patients. J Am Paraplegia Soc. 1991;14(4):200.
24. Sherman RA, Wyle FA, Vulpe M. Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med. 1995;18(2):71-4.
25. Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care. 1998;21(11):2030-1.
26. Fleischmann W, Russ M, Moch D, Marquardt C. Biosurgery: maggots, are they really the better surgeons? Chirurg. 1999;70(11):1340-6.
27. Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability. 2000;10(3):91-4.
28. Markevich YO, McLeod-Roberts J, Mousley M, Melloy E. Maggot therapy for diabetic neuropathic foot wounds: a randomized study. Presented at: 36th Annual Meeting of the European Association for the Study of Diabetes. Jerusalem, Israel. September, 2000.
29. Sherman RA, Sherman J, Gilead L, Lipo M, Mumcuoglu KY. Maggot débridement therapy in outpatients. Arch Phys Med Rehabil. 2001;82(9):1226-9.
30. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10(4):208-14.
31. Jukema GN, Menon AG, Bernards AT, Steenvoorde P, Rastegar AT, van Dissel JT. Amputation-sparing treatment by nature: "surgical" maggots revisited. Clin Infect Dis. 2002;35(12):1566-71.
32. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care. 2003;26(2):446-51.
33. Sherman RA, Shimoda KJ. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection. Clin Infect Dis. 2004;39(7):1067-70.
34. Sherman RA, Shapiro CE, Yang RM. Maggot therapy for problematic wounds: uncommon and off-label applications. Adv Skin Wound Care. 2007;20(11):602-10.
35. Hobson RP. On an enzyme from blow-fly larvae (Lucilia sericata) which digests collagen in alkaline solution. Biochem J. 1931;25(5):1458-63.
36. Hobson RP. Studies on the nutrition of blow fly larvae. III: the liquefaction of muscle. J Exp Biol. 1932;9(4):359-65.
37. Fletcher F, Haub JG. Digestion in blowfly larvae, Phormia regina Meigen, used in the treatment of osteomyelitis. Ohio J Science. 1933;33(2):101-9.
38. Slocum MA, McClellan RH, Messer FC. Investigation into the modes of action of blow fly maggots in the treatment of chronic osteomyelitis. Penn Med J. 1933;36:570-3.
39. Maseritz IH. Digestion of bone by larvae of Phormia regina. Arch Surg. 1934;28(3):589-607.
40. Gwatkin R, Fallis AM. Bactericidal and antigenic qualities of the washings of blowfly maggots. Can J Res. 1938;16:343-52.
41. Ziffren SE, Heist HE, May SC, Womack NA. The secretion of collagenase by maggots and its implication. Ann Surg. 1953;138(6):932-4.
42. Waterhouse DF, Irzykiewicz H. An examination of proteolytic enzymes from several insects for collagenase activity. J Ins. Physiol. 1957;1:18-22.
43. Fraser A, Ring RA, Stewart RK. Intestinal proteinases in an insect, Calliphora vomitoria L. Nature. 1961;192:999-1000.
44. Brookes VJ. Partial purification of a proteolytic enzyme from an insect, Phormia regina. Biochim Biophys Acta. 1961;46:13-21.
45. Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery. 1981;90(5):835-41.
46. Pendola S, Greenberg B. Substrate-specific analysis of proteolytic enzymes in the larval midgut of Calliphora vicina. Ann Entomol Soc Am. 1975;68:341-5.
47. Casu RE, Pearson RD, Jarmey JM, Cadogan LC, Riding GA, Tellam RL. Excretory/secretory chymotrypsin from Lucilia cuprina: purification, enzymatic specificity and amino acid sequence deduced from mRNA. Insect Mol Biol. 1994;3(4):201-11.
48. Muharsini S, Dalrymple B, Vuocolo T, Hamilton S, Willadsen P, Wijffels G. Biochemical and molecular characterization of serine proteases from larvae of Chrysomya bezziana, the Old World Screwworm fly. Insect Biochem Mol Biol. 2001;31(11):1029-40.
49. Chambers L, Woodrow S, Brown AP, Harris PD, Phillips D, Hall M, Church JC, Pritchard DI. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol. 2003;148(1):14-23.
50. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in vivo results. J Tissue Viability. 2004;14(3):97-101.
51. Armstrong DG, Salas P, Short B, Martin BR, Kimbriel HR, Nixon BP, Boulton AJ. Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc. 2005;95(3):254-7.
52. Contreras-Ruiz J, Arroyo-Escalante S, Fuentes-Suarez, Adominguez-Cherit J, Sosa-de-Martinez C, Maravilla-Franco E. Maggot therapy and infection control in venous ulcers: a comparative study. Presented at: Symposium on Advanced Wound Care (SAWC). San Diego, CA. April 21-24, 2005.
53. Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care. 2007;16(9):379-83.
54. Bowling FL, Salgami EV, Boulton AJ. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care. 2007;30(2):370-1.
55. Robinson W, Norwood VH. Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med. 1934;19:581-6.
56. Stewart MA. The role of Lucilia sericata Meig. larvae in osteomyelitis wounds. Ann Trop Med Parasitol. 1934;28:445-60.
57. Simmons SW. The bactericidal properties of excretions of the maggot of Lucilia sericata. Bull Entomol Res. 1935;26:559-63.
58. Messer FC, McClellan RH. Surgical maggots. A study of their functions in wound healing. J Lab Clin Med. 1935;20:1219-26.
59. Pavillard ER, Wright EA. An antibiotic from maggots. Nature. 1957;180(4592):916-7.
60. Greenberg B. Model for the destruction of bacteria in the midgut of blow fly maggots. J Med Entomol. 1968;5(1):31-8.
61. Erdmann GR, Khalil SK. Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol. 1986;23(2):208-11.
62. Keppi E, Zachary D, Robertson M, Hoffmann D, Hoffmann JA. Induced antibacterial proteins in the haemolymph of Phormia terranovae (Diptera): purification and possible origin of one protein. Insect Biochem. 1986;16(2):395-402.
63. Friedman E, Shaharabany M, Ravin S, Golomb E, Gollop N. Partially purified antibacterial agent from maggots displays a wide range of antibacterial activity. Presented at: 3rd International Conference on Biotherapy. Jerusalem, Israel. 1998.
64. Thomas S, Andrews AM, Hay NP, Bourgoise S. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability. 1999;9(4):127-32.
65. Mumcuoglu KY, Miller J, Mumcuoglu M, Friger M, Tarshis M. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol. 2001;38(2):161-6.
66. Lerch K, Linde HJ, Lehn N, Grifka J. Bacteria ingestion by blowfly larvae: an in vitro study. Dermatology. 2003;207(4):362-6.
67. Bexfield A, Nigam Y, Thomas S, Ratcliffe NA. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect. 2004;6(14):1297-304.
68. Huberman L, Gollop N, Mumcuoglu KY, Block C, Galun R. Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J Wound Care. 2007;16(3):123-7.
69. Huberman L, Gollop N, Mumcuoglu KY, Breuer E, Bhusare SR, Shai Y, Galun R. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol. 2007;21(2):127-31.
70. Daeschlein G, Mumcuoglu KY, Assadian O, Hoffmeister B, Kramer A. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol Physiol. 2007;20(2):112-5.
71. Bexfield A, Bond AE, Roberts EC, Dudley E, Nigam Y, Thomas S, Newton RP, Ratcliffe NA. The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect. 2008;10(4):325-33.
72. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA. Maggot therapy: the science and implication for CAM. Part II: maggots combat infection. Evid Based Complement Alternat Med. 2006;3(3):303-8.
73. Wollina U, Liebold K, Schmidt WD, Hartmann M, Fassler D. Biosurgery supports granulation and debridement in chronic wounds: clinical data and remittance spectroscopy measurement. Int J Dermatol. 2002;41(10):635-9.
74. Robinson W. Stimulation of healing in non-healing wounds by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg. 1935;17:267-71.
75. Prete P. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 1997;60(8):505-10.
76. Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol. 2003;148(5):923-33.
77. Horobin AJ, Shakesheff KM, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen. 2005;13(4):422-33.
78. Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol. 2006;126(6):1410-8.
79. Van der Plas MJ, Jukema GN, Wai SW, Dogterom-Ballering HC, Lagendijk EL, van Gulpen C, van Dissel JT, Bloemberg GV, Nibbering PH. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother. 2008;61(1):117-22.
80. Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol. 2000;45:55-81.
81. Jones M, Thomas S. Larval therapy. Nurs Stand. 2000;14(20):47-51.
82. Sherman RA. Maggot therapy for foot and leg wounds. Int J Low Extrem Wounds. 2002;1(2):135-42.
83. Nguyen H, Sherman RA. Adverse events associated with maggot therapy: phase 4 post-marketing study. Presented at: Clinical Symposium on Advances in Skin and Wound Care. Orlando, FL. September 28-October 1, 2006.
84. Thomas S, Jones M, Wynn K, Fowler T. The current status of maggot therapy in wound healing. Br J Nurs. 2001;10(22 Suppl):S5-8, S10, S12.
85. Steenvoorde P, Buddingh TJ, van Engeland A, Oskam J. Maggot therapy and the "yuk" factor: an issue for the patient? Wound Repair Regen. 2005;13(3):350-2.
86. Sherman RA, Nguyen, H, Sullivan R, Mendez S, Carmean M. Why not maggots? Factors affecting therapists' decisions about using maggot debridement therapy. Presented at: 20th Annual Symposium on Advanced Wound Care and Wound Healing Society Meeting. Tampa, FL. April 28-May 1, 2007.
87. Thomas S. Cost of managing chronic wounds in the U.K., with particular emphasis on maggot debridement therapy. J Wound Care. 2006;15(10):465-9.
88. Lodge A, Jones M, Thomas S. Maggots 'n' chips: a novel approach to the treatment of diabetic ulcers. Br J Community Nurs. 2006;11(12):suppl 23-6.
89. Steenvoorde P, Jacobi CE, Oskam J. Maggot debridement therapy: free-range or contained? An in vivo study. Adv Skin Wound Care. 2005;18(8):430-5.